Sophie Stukas
2215 Wesbrook Mall, V6T 1Z3
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Biases and consistency of different assay methods for neurological biomarkers using Quanterix single-molecule-array technology: A secondary analysis method comparison study.
Journal: NeuroMarkers
Published: May 14, 2026
Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical Trial.
Journal: JAMA neurology
Published: June 30, 2025
Characterizing the physiology of circulatory arrest in humans.
Journal: Nature medicine
Published: March 11, 2025
Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer's disease.
Journal: Alzheimer's research & therapy
Published: January 08, 2025
Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls.
Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: September 05, 2024
The role of C-reactive protein and ferritin in the diagnosis of HLH, adult-onset still's disease, and COVID-19 cytokine storm.
Journal: Scientific reports
Published: July 25, 2024
APOE ε4 carrier status modifies plasma p-tau181 concentrations in cognitively healthy super-seniors.
APOE ε4 carrier status modifies plasma p-tau181 concentrations in cognitively healthy super-seniors.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: December 18, 2023
Pediatric reference intervals for serum neurofilament light and glial fibrillary acidic protein using the Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) cohort.
Journal: Clinical chemistry and laboratory medicine
Published: June 27, 2023
Last Updated: 09/26/2026